The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 19, 2018

Filed:

Dec. 03, 2014
Applicant:

Drk-blutspendedienst Baden-württemberg-hessen Ggmbh, Frankfurt am Main, DE;

Inventors:

Jörg Schüttrumpf, Frankfurt, DE;

Patricia Quade-Lyssy, Mainz-Kastel, DE;

Peter Milanov, Frankfurt, DE;

Erhard Seifried, Frankfurt am Main, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/711 (2006.01); C07H 21/04 (2006.01); C12N 9/64 (2006.01); C07K 14/745 (2006.01); A61K 38/48 (2006.01); C12Q 1/56 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 9/644 (2013.01); A61K 38/4846 (2013.01); C07K 14/745 (2013.01); C12Q 1/56 (2013.01); C12Y 304/21022 (2013.01); A61K 38/00 (2013.01); G01N 2333/9645 (2013.01); G01N 2500/04 (2013.01); G01N 2500/20 (2013.01);
Abstract

The present invention relates to variants of factor IX (F.IX) or activated factor IX (F.IXa), wherein the variant is characterized in that it has clotting activity in absence of its cofactor. The present invention furthermore relates to variants of factor IX (F.IX) or activated factor IX (F.IXa), wherein the variant is characterized in that it has increased F.IX clotting activity compared to wildtype. The present invention furthermore relates to the use of these variants for the treatment and/or prophylaxis of bleeding disorders, in particular hemophilia A and/or hemophilia B or hemophilia caused or complicated by inhibitory antibodies to F.VIII. The present invention also relates to further variants of factor IX (F.IX) which have desired properties and can, thus be tailored for respective specific therapeutic applications.


Find Patent Forward Citations

Loading…